Douglas K. Rush

935 total citations
27 papers, 815 citations indexed

About

Douglas K. Rush is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Douglas K. Rush has authored 27 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Organic Chemistry. Recurrent topics in Douglas K. Rush's work include Cholinesterase and Neurodegenerative Diseases (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Memory and Neural Mechanisms (6 papers). Douglas K. Rush is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Memory and Neural Mechanisms (6 papers). Douglas K. Rush collaborates with scholars based in United States, Germany and France. Douglas K. Rush's co-authors include Ursula Schindler, Gina M. Bores, David E. Selk, Francis P. Huger, Hugo M. Vargas, Wayne W. Petko, Fernando Camacho, Abdul Mutlib, Raymond W. Kosley and Luther Davis and has published in prestigious journals such as Radiology, Neuroscience and Journal of Medicinal Chemistry.

In The Last Decade

Douglas K. Rush

25 papers receiving 752 citations

Peers

Douglas K. Rush

PHARM

CMN

Takashi Kosasa Japan

Lawrence V. Majovski United States

K. H. Tachiki United States

Marek Samochocki Poland

H. OGURA Japan

Stefania Ruiu Italy

Andres D. Ramirez United States

Laura A. Craig Canada

Manavi Chatterjee India

Corina Bejar Israel

Takashi Kosasa Japan

Douglas K. Rush

476 ×1.3

PHARM

301 ×1.2

CMN

293 ×1.2

107 ×0.5

91 ×0.6

Citations per year, relative to Douglas K. Rush Douglas K. Rush (= 1×) peers Takashi Kosasa

Countries citing papers authored by Douglas K. Rush

Since Specialization

Citations

This map shows the geographic impact of Douglas K. Rush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas K. Rush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas K. Rush more than expected).

Fields of papers citing papers by Douglas K. Rush

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas K. Rush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas K. Rush. The network helps show where Douglas K. Rush may publish in the future.

Co-authorship network of co-authors of Douglas K. Rush

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas K. Rush. A scholar is included among the top collaborators of Douglas K. Rush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas K. Rush. Douglas K. Rush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rush, Douglas K., et al.. (2016). First Do No Harm: A Title I Natural Quasi-Experiment. Journal of Education and Human Development. 5(2). 1 indexed citations

Smith, Craig P., Gina M. Bores, Wayne W. Petko, et al.. (1997). Pharmacological Activity and Safety Profile of P10358, a Novel, Orally Active Acetylcholinesterase Inhibitor for Alzheimer’s Disease. Journal of Pharmacology and Experimental Therapeutics. 280(2). 710–720. 35 indexed citations

Klein, Joseph, Gina M. Bores, Fernando Camacho, et al.. (1997). Synthesis and preliminary structure-activity relationships of 1-[(3-fluoro-4-pyridinyl)amino]-3-methyl-1H-indol-5-yl methyl carbamate (P10358), a novel acetylcholinesterase inhibitor. Bioorganic & Medicinal Chemistry Letters. 7(2). 157–162. 19 indexed citations

Smith, Craig P., Roy Corbett, Roger D. Porsolt, et al.. (1997). Anti‐Obsessional and Antidepressant Profile of Besipirdine. CNS Drug Reviews. 3(1). 1–23. 9 indexed citations

Szczepanik, A. M., et al.. (1996). Effects of chronic intrahippocampal infusion of lipopolysaccharide in the rat. Neuroscience. 70(1). 57–65. 33 indexed citations

Bores, Gina M., Francis P. Huger, Wayne W. Petko, et al.. (1996). Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 728–738. 222 indexed citations

Jackson, William James, et al.. (1995). Velnacrine maleate improves delayed matching performance by aged monkeys. Psychopharmacology. 119(4). 391–398. 14 indexed citations

Fink, David M., et al.. (1995). Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 38(18). 3645–3651. 28 indexed citations

Szewczak, Mark R., Roy Corbett, Douglas K. Rush, et al.. (1995). The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.. Journal of Pharmacology and Experimental Therapeutics. 274(3). 1404–1413. 43 indexed citations

10.

Rush, Douglas K., et al.. (1994). Synthesis, Resolution, and SAR of (.+-.)-2-Amino-N-methyl-.alpha.-(3-methyl-2-thienyl)benzeneethanamine and Related Analogs as Noncompetitive NMDA Antagonists with Neuroprotective Properties. Journal of Medicinal Chemistry. 37(19). 3008–3015. 3 indexed citations

11.

Hartman, Harold B., et al.. (1992). 3[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]-2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia. Journal of Medicinal Chemistry. 35(14). 2712–2715. 31 indexed citations

12.

Rush, Douglas K., et al.. (1992). Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?. Neurobiology of Aging. 13(5). 591–594. 67 indexed citations

13.

SHUTSKE, G. M., et al.. (1992). Synthesis and biological activity of putative mono-hydroxylated metabolites of velnacrine. Bioorganic & Medicinal Chemistry Letters. 2(8). 865–870. 12 indexed citations

14.

Rush, Douglas K., et al.. (1992). Memory modulation with peripherally acting cholinergic drugs. Psychopharmacology. 106(3). 375–382. 26 indexed citations

15.

Rush, Douglas K.. (1988). Scopolamine amnesia of passive avoidance: A deficit of information acquisition. Behavioral and Neural Biology. 50(3). 255–274. 122 indexed citations

16.

Rush, Douglas K., et al.. (1987). Memory enhancement with tenilsetam antagonism of scopolamine and cycloheximide induced amnesia of passive avoidance in mice. The Society for Neuroscience Abstracts. 13(2). 847. 1 indexed citations

17.

Schindler, Ursula, et al.. (1984). Nootropic drugs: Animal models for studying effects on cognition. Drug Development Research. 4(5). 567–576. 105 indexed citations

18.

Rush, Douglas K.. (1982). A two-way shuttlebox for testing nonhuman primates. Behavior Research Methods. 14(1). 16–18. 3 indexed citations

19.

Mineka, Susan & Douglas K. Rush. (1978). Attachment theories maltreated?. Behavioral and Brain Sciences. 1(3). 453–454. 1 indexed citations

20.

Rush, Douglas K., et al.. (1965). Pulmonary Aspergilloma. Diseases of the Chest. 47(3). 343–345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact